Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL
- 31 July 2010
- journal article
- research article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 46 (10), 1848-1855
- https://doi.org/10.1016/j.ejca.2010.03.026
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Autoantigenic nuclear proteins of a clinically atypical renal vasculitisJournal of Autoimmune Diseases, 2008
- Gender Differences in Sleep, Fatigue, and Daytime Activity in a Pediatric Oncology Sample Receiving DexamethasoneJournal of Pediatric Psychology, 2007
- CCAAT enhancer binding protein β and hepatocyte nuclear factor 3β are necessary and sufficient to mediate dexamethasone-induced up-regulation of alpha2HS-glycoprotein/fetuin-A gene expressionJournal of Molecular Endocrinology, 2006
- Prevalence and Correlates of Fatigue in Long-Term Survivors of Childhood LeukemiaJournal of Clinical Oncology, 2005
- Pharmacokinetics and Pharmacodynamics of Systemically Administered GlucocorticoidsClinical Pharmacokinetics, 2005
- Pharmacogenetic Risk Factors for Osteonecrosis of the Hip Among Children With LeukemiaJournal of Clinical Oncology, 2004
- A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related SymptomsNeuroimmunomodulation, 2004
- Clinical Factors Associated With Cancer-Related Fatigue in Patients Being Treated for Leukemia and Non-Hodgkin's LymphomaJournal of Clinical Oncology, 2002
- Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995Leukemia, 2000
- Molecular evidence for human alpha2-HS glycoprotein (AHSG) polymorphismHuman Genetics, 1996